Overview

Erythropoietin and Iron Supplementation for Patients With Chemotherapy-induced Anaemia

Status:
Unknown status
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
A multicentre, randomized, open-label, parallel-group, active controlled non-inferiority study
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai East Hospital
Treatments:
Dextrans
Epoetin Alfa
Iron
Iron-Dextran Complex